James George Robinson - 25 Apr 2023 Form 4/A - Amendment Insider Report for NYMOX PHARMACEUTICAL CORP (NYMXF)

Role
Director, 10%+ Owner
Signature
James George Robinson
Issuer symbol
NYMXF
Transactions as of
25 Apr 2023
Transactions value $
$36,800
Form type
4/A - Amendment
Filing time
26 Jun 2023, 10:27:04 UTC
Date Of Original Report
27 Apr 2023
Previous filing
06 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NYMXF Common Stock Purchase $18K +40K +0.85% $0.45 4.74M 25 Apr 2023 Direct
transaction NYMXF Common Stock Purchase $18.8K +40K +0.84% $0.47 4.78M 27 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.